ABSTRACT
The goal of predictive analytics monitoring is the early detection of patients at high risk of subacute potentially catastrophic illnesses. An excellent example of a targeted illness is respiratory failure leading to urgent unplanned intubation, where early detection might lead to interventions that improve patient outcomes. Previously, we identified signatures of this illness in the continuous cardiorespiratory monitoring data of Intensive Care Unit patients and devised algorithms to identify patients at rising risk. Here, we externally validated three logistic regression models to estimate the risk of emergency intubation developed in Medical and Surgical ICUs at the University of Virginia. We calculated the model outputs for more than 8000 patients in the University of California – San Francisco ICUs, 240 of whom underwent emergency intubation as determined by individual chart review. We found that the AUC of the models exceeded 0.75 in this external population, and that the risk rose appreciably over the 12 hours before the event. We conclude that there are generalizable physiological signatures of impending respiratory failure in the continuous cardiorespiratory monitoring data.
Competing Interest Statement
Moorman and Clark are officers and own stock in Advanced Medical Predictive Devices, Diagnostics, and Displays, Charlottesville, VA.
Funding Statement
No extramural funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approved by IRBs at UCSF and the University of Virginia with waiver of consent
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
EMAIL ADDRESSES Rachael A Callcut: Racallcut{at}ucdavis.edu
Yuan Xu: Aayuan.Xu{at}gmail.com
Christina Tsai: ChristinaTsai{at}ucsf.edu
Andrea Villaroman: Villaroman.andrea{at}gmail.com
Anamaria Robles: Anarobles{at}ucdavis.edu
Doug Lake: DEL2K{at}hscmail.mcc.virginia.edu
Matthew Clark: mclark{at}amp3d.biz
J Randall Moorman: rm3h{at}virginia.edu
Xiao Hu: Xiao.Hu{at}duke.edu
CONFLICTS OF INTEREST: Moorman and Clark are officers and own stock in Advanced Medical Predictive Devices, Diagnostics, and Displays Inc
FINANCIAL DISCLOSURES: Dr. Callcut is supported by a Career Development Award from the NIH Big Data to Knowledge Initiative (NIH K01ES026834).
Minor text revisions; addition of a second panel to Figure 1; change in author order.
Data Availability
N/A
